EUR/USD 1.18245
0.058%
Gold 5053.41
2.164%
Oil 63.074
-0.864%
USD/JPY 156.485
0.455%
GBP/USD 1.37140
0.120%
GBP/JPY 214.608
0.583%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On February 4th, Jianyou Pharmaceutical announced that its subsidiary, Jianjin Pharmaceutical Co., Ltd., recently received ANDA approval (ANDA No.: 219472) from the U.S. Food and Drug Administration for its selenite injection (600mcg/10mL). This drug is indicated for adult and pediatric patients requiring parenteral nutrition as a source of selenium in parenteral nutrition solutions when oral or enteral nutrition is not feasible, insufficient, or contraindicated. Currently, five generic versions of selenite injection have been approved for marketing in the United States. The company has invested approximately RMB 6.5605 million in research and development for this project. The newly approved product is expected to have a positive impact on the companys operating performance.Venezuelas chief economic advisor: We hope Venezuela will be known as one of the countries with the highest oil production levels.On February 4th, the Hong Kong Securities and Futures Commission (SFC) issued a circular expressing serious concern about issues arising during the surge in new listing applications expected in 2025. These issues included serious deficiencies in the preparation of some listing documents, potential misconduct by sponsors, and serious errors in resource management. On the same day, it was learned from the Hong Kong Stock Exchange (HKEX) that HKEX CEO Chen Yiting welcomed the SFCs circular, considering it a "friendly reminder." Regarding existing listing applications, the SFC warned in the circular that if a sponsors responses to the regulator are seriously incomplete or unsatisfactory, or if the SFC deems the listing documents unreasonably lengthy, the review process may be suspended. As of December 31, 2025, the review process for 16 listing applications has been suspended. The SFC will notify its regulatory peers of these suspensions.February 4 - On the afternoon of February 4, Xi Jinping, General Secretary of the CPC Central Committee and President of China, met at the Great Hall of the People with Le Hoai Trung, member of the Politburo and Minister of Foreign Affairs of the Communist Party of Vietnam, who was visiting as a special envoy of To Lam, General Secretary of the Communist Party of Vietnam.Supermicro (SMCI.O) shares surged 10.8% in pre-market trading after the company raised its annual revenue forecast.

Forecast for Gold: XAUUSD retreats from $1800 on rising US yields

Daniel Rogers

Aug 12, 2022 11:59

 截屏2022-06-07 下午5.14.22.png

 

While it had been trending upwards, gold's daily performance took a sour turn and it is now trading below $1800. During the American session, the XAUUSD reached a high of $1799 before turning down and heading below $1785.

 

Despite predictions of a 0.2% monthly increase, data released on Thursday indicated that the US Producer Price Index decreased by 0.5% in July, bringing the annual rate down to 9.8%. The Consumer Price Index did not move in July, contrary to predictions of a 0.2% increase, according to data released on Wednesday. The US currency fell because of the inflation rate going down.

 

Investors continue to count on a rate hike of 50 basis points or more from the Federal Reserve at their September meeting. U.S. rates have risen despite though a peak in US inflation is more likely, which is surprising. Both the US 10-year yield (now at 2.83%) and the 2-year yield (3.20%) are at their highest levels in nearly a week.

 

Increased US yields capped gold's gains. The inability of the XAU/USD pair to maintain a price over $1800 despite the recent US data has fueled skepticism that the rally will continue. Weekly support is found around $1774, and the immediate support is at $1785. Additional gains appear likely if the price of gold can consolidate over $1800.


Suggestion